Domov › Rakovina pľúc › Connecticut › New Haven
Klinické štúdie Rakovina pľúc v meste New Haven, CT
22 štúdií pre Rakovina pľúc hľadá účastníkov v zariadeniach v meste New Haven a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Prebieha náborFáza 3
- Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven · 3 míľ odtiaľ
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Prebieha náborFáza 3
- Yale University, New Haven
- Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven · 3 míľ odtiaľ
- Yale-New Haven Hospital North Haven Medical Center, North Haven · 7 míľ odtiaľ
- a 2 ďalších
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Prebieha náborFáza 3
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · 7 míľ odtiaľ
- Smilow Cancer Hospital-Derby Care Center, Derby · 8 míľ odtiaľ
- a 1 ďalších
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Prebieha náborFáza 1/2
- Yale Cancer Center, New Haven
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Prebieha náborFáza 2
- Yale Cancer Center, New Haven
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Prebieha náborFáza 3
- Yale University, Smillow Cancer Center, New Haven
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
Prebieha náborFáza 1
- Smilow Cancer Hospital - Yale New Haven Health, New Haven
- Yale - New Haven Hospital - Yale Cancer Center, New Haven
- Smilow Cancer Hospital Phase 1 Unit, New Haven
- a 1 ďalších
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Prebieha náborFáza 2
- Research Site, New Haven
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
Prebieha náborFáza 1/2
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · 7 míľ odtiaľ
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Prebieha náborFáza 1
- Yale Cancer Center, New Haven
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Prebieha náborFáza 1/2
- Yale University School of Medicine - Yale Cancer Center, New Haven
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Prebieha náborFáza 3
- Yale University School of Medicine, New Haven
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Prebieha náborFáza 1/2
- Avenzo Therapeutics Recruiting Site, New Haven
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Prebieha náborFáza 1
- Yale Cancer Center, New Haven
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Prebieha náborFáza 1
- Xencor Investigative Site, New Haven
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
Prebieha náborFáza 1/2
- Yale University Cancer Center, New Haven
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Prebieha náborFáza 2
- Yale University, New Haven
- Smilow Cancer Hospital-Orange Care Center, Orange · 5 míľ odtiaľ
- Yale-New Haven Hospital North Haven Medical Center, North Haven · 7 míľ odtiaľ
- a 2 ďalších
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Prebieha náborFáza 1
- Smilow Cancer Hospital (Yale University), New Haven
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Prebieha náborFáza 2/3
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · 7 míľ odtiaľ
- Smilow Cancer Hospital-Derby Care Center, Derby · 8 míľ odtiaľ
- a 1 ďalších
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Prebieha náborFáza 2
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · 7 míľ odtiaľ
- Smilow Cancer Hospital-Derby Care Center, Derby · 8 míľ odtiaľ
- a 1 ďalších
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
Prebieha náborVítaní zdravých dobrovoľníkov
- Yale New Haven Medical Center, New Haven
The Natural History and Biological Study of Pulmonary Recurrent Respiratory Papillomatosis (pRRP)
Prebieha náborObservačná štúdia
- Yale School of Medicine, New Haven
Štúdie Rakovina pľúc v iných mestách
- Houston, TX78 štúdií
- Boston, MA62 štúdií
- New York City, NY60 štúdií
- Los Angeles, CA45 štúdií
- Arlington, VA41 štúdií
- Washington, DC41 štúdií
- Chicago, IL41 štúdií
- Baltimore, MD40 štúdií
- Nashville, TN40 štúdií
- St. Louis, MO39 štúdií
- Columbus, OH37 štúdií
- Philadelphia, PA36 štúdií
Iné štúdie v New Haven
- Nemalobunkový karcinóm pľúc41 štúdií
- Rakovina prsníka38 štúdií
- Rakovina (všetky typy)33 štúdií
- Metastatická rakovina23 štúdií
- Skvamóznocelulárny karcinóm hlavy a krku22 štúdií
- Rakovina vaječníkov21 štúdií
- Kolorektálny karcinóm20 štúdií
- Rakovina prostaty20 štúdií
- Akútna myeloidná leukémia17 štúdií
- Porucha používania alkoholu (AUD)17 štúdií
- Predávkovanie opioidmi17 štúdií
- Rakovina pankreasu16 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.